Standard Investments’s AbbVie ABBV Stock Holding History

Standard Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-15,500	Closed	-$1.04M	–	53
2015 Q2	$1.04M	Sell	15,500 -959,500	-98%	-$62.6M	0.06%	91
2015 Q1	$57.1M	Buy	975,000 +150,000	+18%	+$9.06M	3.5%	8
2014 Q4	$54M	Sell	825,000 -575,000	-41%	-$36.3M	2.87%	8
2014 Q3	$80.9M	Buy	+1,400,000	New	+$77.7M	4.31%	5

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Standard Investments's ABBV Position: Q3 2015 in Review

Standard Investments sold out of AbbVie (ABBV) in Q3 2015, closing a stake of 13,484 shares — an estimated $906K sold.

Standard Investments first reported a position in ABBV in Q1 2014 and held it in 6 quarters. The position peaked at $14.4M in Q3 2014. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

Standard Investments reported no remaining AbbVie position as of Q3 2015 after selling out during the quarter.
Standard Investments sold 13,484 AbbVie shares in Q3 2015, an estimated $906K.
Standard Investments first reported a position in AbbVie in Q1 2014 and held it in 6 quarters.
Standard Investments's AbbVie position peaked at $14.4M in Q3 2014.
1,604 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Standard Investments's 13F filing for Q3 2015, filed 16 Nov 2015.